DXCM241220C86000
- 0.03
- 0.000.00%
DexCom Newsroom
Express News | Benzinga Market Summary: S&P Rises On PCE Data, Novo Nordisk Falls On Weight Loss Data, Diabetes Stocks Rise
DexCom, Insulet, Tandem Benefit From Novo Nordisk CagriSema Data
Express News | Shares of Glucose Monitoring Stocks Are Trading Higher Following Weaker-than-expected Weight Loss Data From Novo Nordisk
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Oura Raises $200M With Investment From Dexcom
Oura Boosts Valuation to $5.2B in Latest Funding Round
Diabetes Brands Dexcom, Ozempic, Mounjaro Drive Q3 Convergent TV Ad Engagement
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
DXCM Stock Gains on the Launch of Proprietary Generative AI Platform
AI-Driven Glucose Biosensing: Dexcom's (DXCM) Path To A Comeback
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today
Bernstein Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $150
Tuesday Tech Pull Back After Nasdaq and Bitcoin Record | Live Stock
Dexcom's Over-the-counter Glucose Monitor Now Offers Users an AI Summary of How Sleep, Meals and More Impact Sugar Levels
Dexcom Launches the First Generative AI Platform in Glucose Biosensing
Express News | Alberta Government Lifts Age Restrictions on Continuous Glucose Monitors (Cgm) and Eligible Albertans With Type 1 or Type 2 Diabetes Can Now Access Dexcom G7 Cgm
Alberta Government Lifts Age Restrictions on Continuous Glucose Monitors (CGM) and Eligible Albertans With Type 1 or Type 2 Diabetes Can Now Access Dexcom G7 CGM
Is Dexcom, Inc. (DXCM) the Best Weight Loss Stock to Buy Now According to Hedge Funds?